How good is producing free cash flow when running multiple trials? Just our interest income from our stack of cash covers about 50% of the R&D spend!
Note: Our interest covers double our staff cost. So many other ASX health or biotech's have much higher costs, but constantly burn through 10's of millions a quarter with no revenue in sight!
How good is producing free cash flow when running multiple...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.82 |
Change
0.120(0.61%) |
Mkt cap ! $2.459B | |||
| Open | High | Low | Value | Volume |
| $19.80 | $19.82 | $18.85 | $6.333M | 324.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30 | $19.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.83 | 1160 | 2 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$19.74 |
Change
0.120 ( 0.07 %) |
||||
| Open | High | Low | Volume | ||
| $19.76 | $19.80 | $18.86 | 101075 | ||
| Last updated 15.59pm 06/05/2024 ? | |||||
| NEU (ASX) Chart |